TEM (Tempus) Margin operasi

Simbol lan logo merek Tempus AI, Inc (TEM)

Partnerships with oncology centers and pharmaceutical behemoths to develop AI-driven drugs drive the dynamics of operating margins shown on the GURU.Markets time chart for Tempus AI, Inc (TEM), where the indicator stands at -17.50. Strategic growth is based on the scalable aggregation of genetic data for the sale of analytics, while business resilience is guaranteed by integrated biomaterial collection logistics and diversified supply channels for laboratory resources.

tempus.com (TEM): Margin dodolan operasi saka 15.06.2024 nganti 19.11.2026

Rincian analitis perusahaan Tempus Labs (TEM)

Analisis dhasar perusahaan:tempus.com
Barang utama Tempus AI Inc

Operating margin measures the share of profit from core business processes relative to total revenue, allowing for an assessment of cost management efficiency before accounting for debt obligations and taxes. By analyzing operating margin trends, an investor determines the financial stability of Tempus AI, Inc (TEM), where the monetization of clinical data sets through contracts with pharma behemoths should translate into increased profitability for this high-tech business.

Pesaing langsung

QGEN (Qiagen NV) - Margin operasi|Margin dodolan operasi Ionis Pharma (IONS)|Rentabilitas operasi Repligen Corp (RGEN)|RNA - Rentabilitas dodolan operasi|crisprtx.com - Margin dodolan operasi|Tingkat bathi operasi WGS|RARE - Rentabilitas operasi|Beam Tx (BEAM) - Margin dodolan operasi|SRPT (Sarepta Therapeutics Inc) - Margin dodolan operasi|TWST: Rasio bathi operasi|TXG (10xgenomics.com) - Margin operasi|NTLA (Intellia Therapeutics, Inc.) - Rasio bathi operasi|Rentabilitas operasi Stoke Corp (STOK)|Rentabilitas kegiatan operasi BioLife|Margin operasi WVE (Wave Life Sciences Ltd)|MAZE: Rentabilitas dodolan miturut bathi operasi|Sionna Therapeutics, Inc. - Margin operasi|Tingkat bathi operasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Margin dodolan operasi|QURE - Rentabilitas kegiatan operasi|MGTX (MeiraGTx Corp) - Margin operasi|Rentabilitas dodolan operasi REGENXBIO Inc. RGNX|Rentabilitas operasi Solid Biosciences (SLDB)|Ocugen Corp - Rentabilitas dodolan miturut bathi operasi|Rentabilitas operasi Pacific Biosciences PACB|Rasio bathi operasi BNTC (Benitec)|Design Corp - Margin operasi|Rocket Pharmaceuticals - Rasio bathi operasi|Rentabilitas dodolan miturut bathi operasi 4D Molecular Therapeutics, Inc.|Rentabilitas dodolan operasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Margin operasi|Rentabilitas dodolan operasi Editas EDIT|Margin operasi SLN|ProQR Therapeutics - Rentabilitas dodolan miturut bathi operasi|Margin operasi CDXS (Codexis, Inc.)|SGMO: Rentabilitas dodolan miturut bathi operasi|Nautilus Biotechnology - Margin operasi|Tingkat bathi operasi MGX (Metagenomi, Inc)|DTIL: Margin operasi|GBIO: Rasio bathi operasi|Rentabilitas operasi Boundless Bio Inc.|Margin dodolan operasi Exicure (XCUR)|Margin operasi IMNN|PHIO (Phio Pharmaceuticals Corp.) - Tingkat bathi operasi|Mustang Bio, Inc. - Margin dodolan operasi|RNAZ - Margin dodolan operasi|BNGO: Margin dodolan operasi|APDN (Applied DNA Sciences Inc) - Rentabilitas dodolan miturut bathi operasi|BLUE (Bluebird Bio) - Margin dodolan operasi|ImmunoPrecise Antibodies Ltd - Tingkat bathi operasi|OMGA (Omega Therapeutics Inc) - Margin operasi|Rentabilitas operasi OMIC|Rentabilitas operasi Regulus Therapeutics Inc. (RGLS)|Margin dodolan operasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Margin dodolan operasi|Tingkat bathi operasi TCON|UBX - Rentabilitas operasi